A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

The other side of the coin is that a lot of our patients come in, and they already have damage to the kidney because the diagnosis of lupus nephritis is often made after proteinuria has achieved a ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Lupus is a chronic autoimmune condition that may cause inflammation in one or more organs, such as your kidneys, skin, and heart. Asthma is also a chronic inflammatory health condition ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.  Obinutuzumab is a monoclonal ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and ...

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on ...